SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001640334-24-000708
Filing Date
2024-04-30
Accepted
2024-04-30 15:13:55
Documents
17
Period of Report
2024-04-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K lxrp_8k.htm   iXBRL 8-K 34935
2 EX-4.1 lxrp_ex41.htm EX-4.1 95561
3 EX-10.1 lxrp_ex101.htm EX-10.1 43782
  Complete submission text file 0001640334-24-000708.txt   352809

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA lxrp-20240430.xsd EX-101.SCH 5947
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE lxrp-20240430_lab.xml EX-101.LAB 16252
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lxrp-20240430_cal.xml EX-101.CAL 898
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lxrp-20240430_pre.xml EX-101.PRE 11938
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lxrp-20240430_def.xml EX-101.DEF 4194
20 EXTRACTED XBRL INSTANCE DOCUMENT lxrp_8k_htm.xml XML 5586
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 001-39874 | Film No.: 24896643
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)